6505--Pantoprazole RFP

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NAC PHARMACEUTICALS (36E797)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36E79727R0004

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The Department of Veterans Affairs (VA) National Acquisition Center (NAC) has announced a forthcoming Request for Proposal (RFP), identified as 36E79727R0004, for the supply of Pantoprazole Sodium (NA) Tablets. This presolicitation notice outlines the VA’s intent to establish an unrestricted procurement contract to ensure a continuous and reliable supply of Pantoprazole NA Tablets for multiple federal agencies, including the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The primary objective of this procurement is to secure a single, responsible contractor capable of providing uninterrupted delivery of the specified pharmaceutical products over a potential five-year period—comprising an initial one-year base contract with four additional pre-priced one-year option periods. The awarded contract will support the agencies’ respective Pharmaceutical Prime Vendor Programs, facilitating efficient distribution and supply chain management. Key requirements for this solicitation include the provision of Pantoprazole NA Tablets in various strengths and packaging configurations. The estimated annual requirements are as follows: - Pantoprazole NA 20mg Tablets: - 90-count bottles: 244,641 units - 500-count bottles: 28,376 units - OR 1000-count bottles: 14,188 units - Pantoprazole NA 40mg Tablets: - 90-count bottles: 965,273 units - 500-count bottles: 237,162 units - OR 1000-count bottles: 118,581 units Offerors must clearly state the exact product name as it appears on the label and provide a unique National Drug Code (NDC) number for each item offered. Notably, glass bottles are not acceptable packaging for this procurement. The solicitation will be issued electronically in accordance with FAR Part 12 (Commercial Item Acquisition) and will be available for download at http://www.sam.gov. No paper copies will be provided, and all amendments or additional documents will be posted exclusively online. Interested parties are encouraged to monitor the SAM.gov listing for updates and changes to the solicitation. This opportunity is classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing), as per the 2022 NAICS version, and falls under Product Service Code 6505 (Drugs and Biologicals). The procurement is not set aside for any specific business category, making it open to all responsible sources capable of meeting the requirements. The contracting entity for this procurement is NAC Pharmaceuticals (36E797), a federal office within the Department of Veterans Affairs. The primary point of contact for this solicitation is Amber Zavala, who can be reached via email at [email protected] or by phone at (708) 786-5245. The anticipated release date for the solicitation is on or about December 22, 2026, with a tentative closing date of January 5, 2027. All timely and compliant offers will be considered. Contractors with the capability to supply Pantoprazole NA Tablets in the specified quantities and packaging, and who can ensure a consistent and reliable supply chain, are encouraged to review the full solicitation upon its release and consider submitting a proposal.